SCHEMBL7220329

SCHEMBL7220329

CCCCCCCCOc1cc(C)c(N)c(C)c1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.54
THRB P10828 6/20 0.50
PLA2G2A P14555 2/20 0.50
THRA P10827 2/20 0.50
NR5A1 Q13285 1/20 0.47
BLM P54132 1/20 0.44
TP53 P04637 2/20 0.42
NPC1 O15118 1/20 0.42
LMNA P02545 1/20 0.42
GAA P10253 1/20 0.42
MAPT P10636 1/20 0.42
ALOX15 P16050 1/20 0.42
RAB9A P51151 1/20 0.42
HSD17B10 Q99714 1/20 0.42
LTA4H P09960 1/20 0.42
PLA2G4B P0C869 1/20 0.41
PDIA6 Q15084 1/20 0.41
DHFR P00374 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19480454 1.00 TSHR (0.54) TSHRTHRBPLA2G2ATHRANR5A1
SCHEMBL6460166 0.98 TSHR (0.51) TSHRTHRBPLA2G2ATHRANR5A1
SCHEMBL7225914 0.92 TSHR (0.44) TSHRTHRBPLA2G2ATHRANR5A1
SCHEMBL5028320 0.86 ALDH1A1 (0.42) TSHRTP53NPC1LMNAGAA
SCHEMBL15298486 0.84 PLA2G2A (0.53) TSHRTHRBPLA2G2ATHRANR5A1
SCHEMBL19141798 0.82 TSHR (0.56) TSHRPLA2G2ANR5A1BLMTP53
SCHEMBL18886699 0.81 PLA2G2A (0.68) TSHRTHRBPLA2G2ATHRANR5A1
SCHEMBL9016884 0.81 PLA2G2A (0.68) TSHRTHRBPLA2G2ATHRANR5A1
SCHEMBL8644570 0.81 THRB (0.50) TSHRTHRBPLA2G2ATHRANR5A1
SCHEMBL20503338 0.81 THRB (0.50) TSHRTHRBPLA2G2ATHRANR5A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6576791-B1 Local anesthetic compounds and uses THERAVANCE, INC. 2003-06-10 US disclosed
US-6495681-B1 PRODUCING LOCAL ANESTHESIA OF LONG-DURATION. THE COMPOUNDS OF THIS INVENTION ARE MULTIBINDING COMPOUNDS THAT COMPRISE FROM 2 TO 10 LIGANDS COVALENTLY ATTACHED TO A LINKER OR LINKERS, EACH LIGAND BEING CAPABLE OF BINDING TO A LIGAND BINDING SITE THERAVANCE INC. 2002-12-17 US disclosed
US-6462034-B1 MULTIBINDING COMPOUNDS CONTAINING A SYMETRICAL DIAMINOTETRA-ETHERDODECANE RING WITH TWO SECONDARY AMIDE AND ADDITIONAL SUBSTITUENTS; VOLTAGE GATED SODIUM CHANNEL MODULATORS; LONG DURATION THERAVANCE, INC. 2002-10-08 US disclosed
US-6337423-B1 BIND TO VOLTAGE-GATED SODIUM ION CHANNELS TO MODULATE ACTIVITY ADVANCED MEDICINE, INC. 2002-01-08 US disclosed
CN-1295558-A Novel local anesthetic compounds and uses ADVANCED MEDICINE INC (US) 2001-05-16 CN disclosed
EP-1066245-A4 NOVEL LOCAL ANESTHETIC COMPOUNDS AND USES ADVANCED MEDICINE INC (US) 2001-01-24 EP disclosed
EP-1066245-A1 NOVEL LOCAL ANESTHETIC COMPOUNDS AND USES Advanced Medicine, Inc. (US) 2001-01-10 EP disclosed
WO-1999051565-A9 NOVEL LOCAL ANESTHETIC COMPOUNDS AND USES ADVANCED MEDICINE INC (US) 1999-12-02 WO disclosed
WO-1999051565-A1 NOVEL LOCAL ANESTHETIC COMPOUNDS AND USES ADVANCED MEDICINE, INC. (US) 1999-10-14 WO disclosed